Expressed human milk can be donated or sold through a variety of channels, including human milk banks, corporations or individuals, or peer-to-peer milk sharing. There is a paucity of research regarding the nutrient and bioactive profiles of expressed human milk exchanged through commerce-free scenarios, including peer-to-peer milk sharing. The study objective was to evaluate the macronutrient, antimicrobial protein, and bacteria composition in expressed human milk acquired via commerce-free arrangements. Expressed human milk samples were collected from the following commerce-free scenarios: milk expressed for a mother's or parent's own infant (MOM; N = 30); unpasteurized milk donated to a non-profit milk bank (BANKED; N = 30); milk expressed for peer-to-peer milk sharing (SHARED; N = 31); and health professional-facilitated milk sharing where donors are serologically screened and milk is dispensed raw (SCREENED; N = 30). Analyses were conducted for total protein, lactose, percent fat and water, lysozyme activity, immunoglobulin A (IgA) activity, total aerobic bacteria, coliform, and Staphylococcus aureus. No bacterial growth was observed in 52/121 samples, and 15/121 had growth greater than 5.0 log colony-forming units/mL. There was no evidence of differences by groups (p > .05) in lactose, fat, water, lysozyme activity, sIgA activity, aerobic bacteria, coliforms, and S. aureus.
sharing for the high-risk infant (AAP, 2017) , and the U.S. Food and Drug Administration (FDA) has warned against the sharing or purchasing of human milk directly between individuals, due to the risk of pathogen transmission and exposures to potentially harmful substances (USFDA, 2015b) . Research suggests that human milk sharing should be distinguished from purchasing because it does not involve a monetary exchange (Gribble & Hausman, 2012; Palmquist & Doehler, 2016; Rasmussen, Felice, O'Sullivan, Garner, & Geraghty, 2017; Reyes-Foster et al., 2015) .
Despite warnings from the AAP and FDA, there is growing evidence of active milk sharing communities in the United States, often facilitated by the Internet (Palmquist & Doehler, 2014; Perrin et al., 2014; Reyes-Foster et al., 2015) . Recent research suggests that lactating women in the United States are generally aware of the concept of peer milk sharing and many are receptive to it (Keim et al., 2014;  O'Sullivan, Geraghty, & Rasmussen, 2016; Perrin et al., 2016) . Additionally, there are case reports of undisclosed use of peer-shared milk in paediatric inpatient settings (Barbas, Sussman-Karten, Kamin, & Huh, 2017) . Collectively, these reports suggest an imperative for health care providers to be able to offer evidence-based guidance about peer-to-peer milk sharing that enables families to make informed decisions.
There is a dearth of studies that have investigated the relative risks, benefits, and costs of milk sharing by examining human milk samples, and only the Australian College of Midwives (Australian College of Midwives, 2014) and the American Academy of Nursing (American Academy of Nursing, 2016) offer evidence-based position statements. Analysis of the U.S. media suggests differing language used to discuss human milk based on the mode of exchange, with human milk received through formal milk banks framed as "liquid gold" while human milk exchanged informally via peers framed as "fool's gold," though limited data exist to support this dichotomous discourse on human milk quality (Carter & Reyes-Foster, 2016 ).
The quality of expressed human milk can be evaluated based on multiple criteria, including the level of potential pathogens and contaminants (the risks) and the level of nutrients and bioactive substances (the benefits). These factors have been studied in human milk donated to HMBANA banks (Cohen, Xiong, & Sakamoto, 2010; Landers & Updegrove, 2010; Perrin, Fogleman, Newburg, & Allen, 2017 ) and in some commercial human milk products (Bloom, 2016; Wojcik, Rechtman, Lee, Montoya, & Medo, 2009) . Globally, there are no agreed upon standards for acceptable bacteria levels in raw human milk in the context of donor milk banking (PATH, 2013) . Recent research into pathogens and contaminants in human milk purchased anonymously on the Internet and shipped to a post office box found high levels of bacterial growth (Keim et al., 2013) evidence of tobacco use and some adulteration with bovine milk ; however, the method of collecting samples for this study did not reflect how milk is exchanged in commerce-free peer sharing arrangements, in which milk is typically delivered face-to-face and ongoing relationships may be established (Palmquist & Doehler, 2016; Reyes-Foster et al., 2015) . Furthermore, the study excluded any sellers who attempted to screen prospective buyers. Emerging evidence suggests that milk recipients participating in commerce-free peer-to-peer milk sharing often employ various forms of screening based on their risk perceptions and relationship with the donor (Palmquist & Doehler, 2016; Reyes-Foster et al., 2015) . Others have reported increased risks of water dilution when donor compensation is deployed (Bloom, 2016) . There is currently no research available on the pathogen or nutrient composition of human milk exchanged through commerce-free peer sharing. The purpose of this study is to evaluate the bacteria, macronutrients, and antimicrobial proteins in human milk shared through a variety of uncompensated channels.
| METHODS
This study was approved by the Institutional Review Boards of Elon University and North Carolina State University (protocol #12-054) and North Carolina State University (protocol #9581). Individual study participants provided informed consent to release their milk for analyses.
Samples received through third-party organizations or community gatekeepers relied on the organization's collection and consent processes, and no additional consent was obtained. All samples were blinded and assigned an anonymous identification number prior to analyses to maintain participant confidentiality and reduce potential researcher bias.
| Participant recruitment
Samples of expressed human milk were solicited via multiple commercefree channels used for human milk donation between September 2015 and March 2016. The treatment groups for this study were as follows: milk expressed by an individual for their own infant (MOM); milk expressed by an individual to share with others or expressed milk received through an uncompensated exchange with a peer (SHARED); milk from a screened donor that was donated to one of three non-profit milk banks in the HMBANA network (BANKED); and milk that was donated to a hybrid milk exchange model that dispenses raw milk from donors who have undergone serological screening (SCREENED). Samples from unique donors were obtained for each study treatment group by recruiting on social networking websites associated with breastfeeding and milk sharing (for MOM and SHARED groups) and by working directly with third-party organizations (WakeMed Mothers' Milk Bank, Raleigh, NC, USA; Mothers' Milk Bank
Key messages
• There is no evidence of differences in the bacteria levels in expressed human milk exchanged through commercefree models, including non-profit milk banking and peer sharing, compared to milk collected for use within the maternal-infant dyad.
• There is no evidence of differences in the macronutrient composition and antimicrobial protein content in expressed human milk by modes of commerce-free exchange. Similarly, there is no evidence of water dilution by method of exchange.
• Evidence-based public health messages about the risks and benefits of commerce-free human milk exchange are needed.
Iowa, Coralville, IA, USA; Oklahoma Mothers' Milk Bank, Oklahoma City, OK, USA; and Mothers' Milk Alliance, Madison, WI, USA). Although no instructions were provided for sample collection so that the study would reflect normal milk expression practices, it is common practice for milk bank donors to receive instructions for collecting and storing human milk.
To reduce the risk for collection bias, we obtained samples that had been expressed prior to study enrolment. Individuals who provided milk were asked to give basic information including date of parturition and date of sample expression to compute a stage of lactation. Using mean and standard deviation values for total protein (1.16 ± 0.25), lactose (7.80 ± 0.88), and total fat (3.22 ± 1.00) reported by Wojcik et al. (2009) in a cross-sectional study of 273 lactating women, the sample size necessary to detect a 20% difference in mean values between two independent groups using a power of 80% and an alpha of 0.05 was 19, 6, and 39 for protein, lactose, and fat, respectively. No adjustment to sample size was made for potential multiple comparisons analysis. Samples collected per treatment group were 30 for MOM, BANKED, and SCREENED and 31 for SHARED. All samples were received in a frozen state and were transported on ice to the laboratory at North Carolina State University where they were thawed, aliquoted, and stored at −80°C until further analysis. Storage duration for each sample was computed using the date at the end of study enrolment (March 31, 2016) less the date that the sample was expressed, and the stage of lactation was computed using the parturition date less the date the sample was expressed. Parturition data were missing for 14/121 samples (11.6%), with the SHARED group having the most missing parturition dates (11/31, 35%).
| Bacterial analysis
Human milk samples were thawed and cultured for total aerobic bacteria, coliform, and Staphylococcus aureus using Petrifilm plates (3 M Company, St. Paul, MN, USA). Total aerobic bacteria and coliform were selected because they are measures of quality used in the bovine milk industry (United States Food and Drug Administration, 2015a), and S. aureus was selected due to case reports of infections via human milk (Gastelum, Dassey, Mascola, & Yasuda, 2005; Kayıran, Can, Kayıran, Ergonul, & Gürakan, 2013) . Samples were analysed in duplicate using various dilutions with sterile 0.1% peptone water. Additional dilutions were used, if needed, to get readings within the ranges stated by the manufacturer. Petrifilm plates were incubated at 35°C per the manufacturer's instructions, and colony-forming units (CFUs) were counted using a light box, magnifier, and hand counter. Petrifilm 
| Macronutrient analysis
Per cent fat and per cent water were measured using an SMART Trac Rapid Moisture/Fat Analyser (CEM Corporation, Matthews, NC, USA), which has previously been validated for use with human milk (Fogleman, 2008) . The CEM Smart Trac combines NMR techniques and microwave drying and has variations less than 3%; therefore, single measurements for fat and water content were obtained. Total protein was measured in triplicate using a Bicinchoninic Acid (BCA) kit (Pierce Biotechnology, Rockford, IL, USA). The BCA assay uses bovine serum albumin as the protein standard and has been shown to have a very high correlation (r = 0.99) with Kjeldahl (Keller & Neville, 1986) as the reference method, which was greater than the correlation seen with the biuret assay (r = 0.96), the Lowery-Peterson assay (r = 0.97), and the Coomassie Blue assay (r = 0.89), though protein tends to be overestimated with BCA compared to Kjeldahl (Keller & Neville, 1986) . The average intraassay coefficient of variation (CV) for total protein was 3.0%. Lactose was measured using a method modified from Upreti, McKay, and
Metzger (2006) 
| Antimicrobial protein analysis
The activity of lysozyme, an antibacterial enzyme that lyses the cell wall of gram-positive and gram-negative bacteria (Chipman & Sharon, 1969; Lönnerdal, 2013; Shah, 2000) , was measured in triplicate based on changes in turbidity to a suspension of Micrococcus lysodeikticus (M3770; Sigma-Aldrich; St. Louis, MO, USA), using methods developed by Shugard (1952) and adapted to run in a 96-well plate (Lee & Yang, 2002) . The average CV for lysozyme activity was 9.6%. The activity of secretory immunoglobulin A (sIgA), a custom antibody to the pathogens found in a mother's environment (Lönnerdal, 2013) , was analysed in triplicate using an enzyme-linked immunosorbent assay that binds human milk IgA between Escherichia coli antigens (Michigan State University; East Lansing, MI, USA) and antihuman IgA peroxidase antibodies (A0295; Sigma-Aldrich), with purified human IgA from colostrum (I2636; Sigma-Aldrich) used as a standard (Chen & Allen, 2001; Viazis, Farkas, & Allen, 2007) . The average CV for sIgA activity was 2.6%.
| Statistical analysis
Data for total protein, per cent fat, and per cent water followed a normal distribution, and data for lactose, lysozyme activity, sIgA activity, bacteria counts, days postpartum, and storage duration followed non-parametric distributions per evaluation with the Shapiro-Wilk test. Differences between treatment groups for numerical data were evaluated using a one-way ANOVA test for normally distributed data and a Kruskal-Wallis test for non-parametric data. Categorical variables were evaluated using a Chi-Square test. Regression analysis was used to evaluate the impact of confounding variables. Data analysis was conducted using SAS Enterprise Edition 9.4 (SAS Software, Cary, North Carolina). (Table 1) . Similarly, the prevalence of samples with limited growth (1.0 log or less), low growth (>1.0 to 3.0 log), moderate growth (>3.0 to 5.0 log), and high growth (>5.0 log) did not differ between exchange methods for total aerobic bacterial counts or coliform counts (Figure 1 ). Twelve per cent of all samples (15/121) had total aerobic bacteria counts above 5.0 Log CFUs/mL, which serves as the cut-off value used by some donor milk bank networks regarding eligibility for donation (Bharadva et al., 2014; UKAMB, 2003) . Across all samples, the median (interquartile range) log CFUs/mL was 2.54 (3.94) for total aerobic bacteria, 0.0 (0.0) for coliform count, and 0.0 (0.0) for S. aureus. There was no evidence of differences in the distribution (median, IQR) of bacteria levels between exchange methods (Table 2) .
| Nutrients and antimicrobial proteins
No evidence of differences in total protein, fat, or water content was observed by treatment group. Mean protein values (95% confidence interval) were 1.5 g/dL (1.4, 1.6) for BANKED, 1.4 g/dL (1.3, 1.5) for MOM, 1.6 g/dL (1.5, 1.7) for SCREENED, and 1.5 g/dL (1.4, 1.6) for SHARED, which was not significantly different (p = .081). Mean fat values (95% confidence interval) were 3.3% (2.9, 3.7) for BANKED, 3.9% (3.3, 4.4) for MOM, 3.7% (3.3, 4.2) for SCREENED, and 3.6% Table 2 .
| Milk attributes
There was no evidence (p = .501) of differences in the distribution of the stage of lactation by treatment group (Table 2) No growth 12 (40) 12 (40) 14 (47) 14 (45) .9310
Note. Number of samples per treatment group (% within treatment group);
*p value for differences in proportion of samples with any growth evaluated with Chi-Square test. Lysozyme (in 1,000 units/mL) 18 (24) 30 (20) 24 (20) 15 (21) .094
Total aerobic count (Log 10 ) 3.0 (4.7) 2.9 (3.9) 0.8 (3.9) 1.2 (3.2) .677
*Normally distributed data reported as means (standard deviation) and evaluated using one-way ANOVA;
**Non-parametric data reported as medians (interquartile range) and evaluated using Kruskal-Wallis test; stdev = standard deviation; IQR = interquartile range; ***Days postpartum data represents n = 30 for BANKED, n = 28 for MOM, n = 30 for SCREENED, and n = 19 for SHARED due to missing data on parturition date.
temperatures above 0°C. Findings from the study for paid and shipped milk may not be generalizable to unpaid models of milk exchange where evidence suggests that milk typically exchanged in person (Palmquist & Doehler, 2016; Reyes-Foster et al., 2015) likely reducing the time that milk may be exposed to improper storage conditions.
There are no agreed upon global standards regarding acceptable prepasteurization bacteria levels for donor human milk. The HMBANA does not define a threshold for accepting donations but defines standards for dispensing unpasteurized milk as "Only milk from pools with <10 4 CFU/mL of normal skin flora (e.g. coagulase negative
Staphylococcus, diphtheroids, Staphylococcus epidermis, Streptococcus viridans) is acceptable to dispense raw. The presence of any pathogens is unacceptable" (HMBANA, 2015) . Several milk banking networks globally set raw milk donation limits at less than 5.0 log CFU/mL for milk that will be subject to pasteurization (Bharadva et al., 2014; Hartmann et al., 2007; UKAMB, 2003) . The FDA's "Grade A Pasteurized Milk Ordinance (PMO)" sets the threshold for total bacteria at 5.0 log CFU/mL for raw bovine milk that is intended for pasteurization, and 4.3 log CFU/mL for Grade "A" pasteurized bovine milk (USFDA, 2015a). Additionally, the PMO sets a threshold for coliform counts, a marker of sanitation, at 10 to 100 coliforms/mL for Grade "A" pasteurized bovine milk (USFDA, 2015a). In this study, 12.4% of samples had total bacteria levels greater than 5.0 log CFU/mL, 24.8% of samples had total bacteria levels greater than 4.0 log CFU/mL, and 16.5% of the samples were positive for coliform (median 0.0; IQR 0.0), with no evidence of differences by method of milk exchange. Thompson et al. (1997) has reported that approximately 35% of expressed human milk samples had bacterial growth greater 5.0 log CFU/mL, with no difference based on whether the breast was washed in advance with water or water and soap. In contrast, in the study of human milk purchased anonymously via the Internet and shipped to a post office box, 74% of samples exceeded 4.0 log CFU/mL of total bacteria, and coliform growth was observed in 44% of the samples (Keim et al., 2013) , which may be explained by poor temperature control during transportation.
The focus on setting a threshold for acceptable bacteria levels in human milk is not well supported by the literature. Law et al. (1989) cultured bacteria in over 10,000 unpasteurized human milk feedings from either a mother or an approved donor that were fed to 98 premature infants during the first 2 weeks of life. During the study, 100% of infants were exposed to CoNS, 41% were exposed to S. aureus, and mean feeding bacteria levels for different species ranged from 4.7 log CFU/mL to 7.5 log CFU/mL. Law et al. (1989) found no relationship between bacteria levels in expressed human milk and feeding intolerance or invasive infection, leading the authors to conclude that "results do not support attempts to define a safe upper limit for bacterial concentration in raw expressed milk." Similarly, Schanler et al. (2011) cultured 813 human milk samples from 161 mothers of preterm infants and found that half of the samples were positive for CoNS, 5% were positive for S. aureus, and over 25% of samples had high bacteria levels defined as greater than 4.0 log CFU/ mL of gram-positive organisms or greater than 3.0 log CFU/ml of gram-negative organisms. All milk samples were collected in a home environment, and milk cultures were not predictive of infectious outcomes in infants.
| Macronutrients and antimicrobial proteins
The present study is the first to examine the macronutrient and antimicrobial protein composition of human milk that is given and received through multiple channels of uncompensated human milk exchange.
The fat and water content of expressed human milk can be manipulated based on whether the sample collected represents a full expression of the breast or whether it is primarily fore or hind milk (Ballard & Morrow, 2013) . We observed no difference in the per cent fat or per cent water, suggesting that uncompensated donors are not intentionally giving low-calorie milk or diluting milk with water. Other researchers have reported water dilution in models where donors are paid by the ounce (Bloom, 2016) . In the present study, there was no evidence of differences in total protein, lactose, lysozyme activity, and sIgA activity between methods of exchange. There are significant variations in lysozyme and sIgA activity between individuals, and concentrations may be influenced based on infant health status and stage of lactation (Breakey, Hinde, Valeggia, Sinofsky, & Ellison, 2015; Perrin et al., 2017) . This study was not powered to detect potential differences in lysozyme or sIgA activity.
| Non-commercial sharing of expressed human milk
Recipients engaged in peer-to-peer milk sharing frequently cite problems establishing or maintaining lactation as a primary motivator for seeking milk (Cassidy, 2012; Gribble, 2014; Palmquist & Doehler, 2014; Perrin et al., 2014) . The only difference in breastfeeding support reported by donors and recipients was from paediatricians and spouses, suggesting that an important point of intervention is beyond the maternity care process (Palmquist & Doehler, 2014) . Child health motivators for seeking shared milk were often related to intolerance of infant formula and poor weight gain and infrequently related to serious medical conditions for the infant (Gribble, 2014; Palmquist & Doehler, 2016; Perrin et al., 2014) . Others have reported a high incidence of perceived formula feeding intolerance in term infants, with 67% of families switching formula brands during the first 6 months of life (Nevo, Rubin, Tamir, Levine, & Shaoul, 2007) .
Facilitating access to a safe supply of donor human milk may be a strategy to support families who are experiencing feeding intolerance with term infants.
There is a lack of evidence regarding health outcomes related to peer-to-peer milk sharing, making it an important area of future research. The evidence of pathogen transmission through human milk is predominantly in the medically fragile population (Decousser et al., 2013; Gastelum et al., 2005; Gras-Le Guen et al., 2003; Rettedal et al., 2012; Ryder, Crosby-Ritchie, McDonough, & Hall, 1977; Stiver, Albritton, Clark, Friesen, & White, 1977; Widger, O'Connell, & Stack, 2010) , though case reports of transmission to term infants also exist, including a recent report of HIV transmission in a developed country (Blumental, Ferster, Van den Wijngaert, & Lepage, 2014 ). An infant's health and age are important factors to consider when weighing risks, costs, and benefits of available infant feeding options. Studies of milk sharing practices in the United States have found that the majority of parents seeking milk through peer-to-peer milk sharing are doing so for infants who are on average 7 months of age and not medically fragile (Palmquist & Doehler, 2014; Palmquist & Doehler, 2016) . In a large observational study of online peer-to-peer milk sharing communities (Perrin et al., 2014) , the predominant child-health-related reason cited for seeking human milk was an intolerance to formula, and the average age of recipient infants was 6.2 months (M.T. Perrin, unplubished data).
These findings support the interpretation that milk sharing increases access to human milk for a population of infants that may not otherwise have access due to a variety of barriers, including lack of eligibility, cost, proximity, and cultural factors.
This study also contributes to a greater understanding of the nutri- Peer-to-peer human milk sharing has been conceptualized as a public health risk by the FDA, the media, and health authorities and organizations in the United States and abroad (Carter & Reyes-Foster, 2016; USFDA, 2015b) . Unfortunately, in the public health literature, milk sharing has been conflated with commercial peer-to-peer enterprises and anonymous purchase of milk, despite studies indicating that peer-to-peer milk sharing does not involve exchange of milk for payment or profit and is rarely anonymous (Palmquist & Doehler, 2016; Reyes-Foster et al., 2015; Reyes-Foster et al., 2017) . Thus, the available literature on human milk exchange and associated risks of contamination may not be an apt representation of the risk of uncompensated peer-to-peer milk sharing.
This study was designed to ascertain the risk of 
| LIMITATIONS
This study was powered to detect differences in protein composition of milk and may not have detected differences in more variable milk components including fat, lysozyme activity, sIgA activity, and bacteria levels; therefore, lack of evidence in difference should be interpreted cautiously. There is the risk that study participants changed their hygiene practices during participation in this study. To counter the risk for collection bias, only human milk samples that had been expressed prior to enrolling in the study were eligible for analysis. Data about stage of lactation are incomplete, often because this information may not have been available for milk collected by milk sharing recipients.
There were significant differences in how long samples had been stored by treatment group, which may have influenced some of the nutrients analysed in this study. 
